AZN vs GIS · P/E 28, $288.38B cap vs P/E 8.2, rev $18.42B
AstraZeneca PLC (AZN) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the AZN and GIS stock pages for the full models.
Not investment advice.